Moreover, Gremlin 1 was identified as a promoter of stem cell maintenance in glioma and colorectal cancer [30,31], and the upregulation of Gremlin 1 significantly correlated with stem cell marker expression and poor survival in estrogen receptor (ER)-negative breast cancer patients [8]. The gene discussed is GREM1; the disease is breast cancer.